Open 2013: Stanford-India Biodesign: Lessons learned from an Indo-US collaboration


Published on

  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Open 2013: Stanford-India Biodesign: Lessons learned from an Indo-US collaboration

  1. 1. STANFORD INDIA BIODESIGNLessons Learned from an Indo-US CollaborationNCIIA Open 2013Ritu Kamal
  2. 2. Disparity in IndiaMumbai 2013
  3. 3. Disparity in Indian Healthcare *Biodesign Fellows
  4. 4. Examples of Medical Technology InnovationWhat is beyond these dated examples? *,
  5. 5. Opportunity for Innovation✤ Healthcare growth drivers are creating opportunities for innovation✤ Low cost, high-quality medical devices need to be created to address unmet needs in India
  6. 6. The Biodesign Process is asystematic approach to medicaltechnology innovation12 year old innovation program based at Stanford University
  7. 7. need concept need need need concept need need concept need need need need need concept need need need need concept FINAL need CONCEPT need need concept need need need need need concept need need need concept need need concept needThe Biodesign Process
  8. 8. 1. NEEDS FINDING 2. NEEDS SCREENING 2.1 2.3 Stakeholder IDENTIFY Disease State Analysis 1.2 Observation 1.3 Fundamentals 2.5 1.1 & Problem Need Statement Needs Strategic Focus Identification Development Filtering 2.2 2.4 Treatment Market Analysis Options 4. CONCEPT SELECTION 3. CONCEPT GENERATION 4.1 4.3 Intellectual Reimbursement INVENT 3.1 3.2 Property Basics Basics 4.6 4.5 Ideation & Concept Final Concept Prototyping Brainstorming Screening Selection 4.2 4.4 Regulatory Business Models Basics 5. DEVELOPMENT STRATEGY & PLANNING 6. INTEGRATION 5.7 Marketing & 5.1 5.4 Stakeholder IP Strategy Regulatory Strategy Strategy 6.1 IMPLEMENT 6.3 Operating Plan & Funding Sources Financial Model 5.5 Quality & 5.8 5.2 Process Sales & Distribution R&D Strategy Management Strategy 6.2 6.4 Licensing & Business Plan Alternate Development Pathways 5.9 Competitive 5.3 5.6 Reimbursement Advantage & Clinical Strategy Strategy Business StrategyIdentify → Invent → Implement
  9. 9. Origins of Stanford India BiodesignNew Delhi, 2006
  10. 10. Goals✤ Identify and train potential leaders in the medical technology innovation in India✤ Develop medical technologies to solve unmet clinical needs in India✤ Fuel the growth of the Indian medical technology industry
  11. 11. Department of Stanford University Biotechnology IIT, Delhi Ministry of Science AIIMS, Delhi and TechnologyCollaborators and Supporters
  12. 12. Program Offerings✤ Stanford-India Biodesign Fellowships✤ India Biodesign Internships at AIIMS/IIT Delhi✤ Global student and faculty exchanges✤ Annual Indian MedTech Summit✤ National SIB Center in Delhi✤ Management workshops✤ networking community
  13. 13. Stanford India Biodesign Fellows 2007-2013
  14. 14. Stanford, CA AIIMS, New Delhi Understand Live ProjectFellowship Year
  15. 15. Clinical ImmersionTertiary and Secondary Healthcare settings
  16. 16. Clinical ImmersionPrimary and Outreach Healthcare settings
  17. 17. SIB Internship✤ Delhi Program trains 5-8 interns yearly✤ Internship lasts 3-4 months✤ SIB Fellows act as mentors✤ Interns have produced innovative products
  18. 18. Indian Medtech SummitHeld Annually in New Delhi2011 attendance - over 300 including participation by the NIH
  19. 19. Indian Medtech Summit2013 Keynote Speaker: State Minister for Higher Education
  20. 20. Launch of National Biodesign CurriculumInnovation Course taught at several engineering colleges
  21. 21. Results✤ >300 applicants to the fellowship each year; 4 selected✤ 25 Fellows trained✤ 28 Interns trained✤ 20 provisional patents filed✤ 6 Summits held✤ 15 devices developed✤ 1 Venture backed company (Consure)✤ 3 Licensed products
  22. 22. Co-Founders: Nish Chasmawala, Amit Sharma, Dr Sandeep Singh Closed first round of venture funding in August 2012 16M patients affected every year No affordable device available • Developed for all stool types and sphincter tones • Easy and hygienic to use (profile and placement) • Reduces nursing time (leakage and dislodgement) • Minimal training requiredProject 1: A novel way to manage fecal incontinence innon-ambulatory patients
  23. 23. Placement Insertion Remove Guide Infuse • Manual operation Team: Jayant Karve, Srinivas Kiran, Dr • Ergonomic design • Sterility maintenance Sandeep Singh • Needle guidance & visibilityProject 2: A better way to gain intraosseous access inemergency patients “IO infusion should be the first alternative to IV in cardiac arrest patients”
  24. 24. 15 Million 5.4 Million Road Traffic Accidents (RTAs) per annum in India Incidence of Lower Limb Injuries in RTAs Team: Pulin Raje, Dr Darshan Nayak • A disposable splint • Easy to use • Ultra low cost • Licensed to Hindustan Latex Limited in Nov 2012Project 3: A better way to temporarily immobilizelower limbs in trauma patients
  25. 25. Screening for all 100,000 are bornhearing impaired in India each year • Low cost hearing screening device • Unique reusable electrode system Team: Nitin Sisodia, Dr Ramesh Agarwal, Dr Rakesh • Novel algorithm Lodha • Novel noise cancellation Project 4: A novel hearing screening device for newborns
  26. 26. Birth Asphyxia: 15,00,000 2,10,000 2.6 crore won’t breathe annual births babies die at birth every year Effective resuscitation can save almost all these Team: Ayesha Chaudhary, Dr Avijit Bansal, Dr Ramesh Agarwal, Dr Rakesh Lodha • Automatically positions neck • In built suction, no power required • Easier better sealing • Objective feedback • Single operator use • Built in timer and heart rate monitorProject 5: An easy to use neonatal resuscitation system
  27. 27. India-Biodesign.orgNetworking website with over 800 members
  28. 28. Thank you